Stereotactic radiotherapy for centrally located stage I lung cancer: results of a 'risk-adapted' 60 Gy scheme

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)S338-S338
JournalJournal of Thoracic Oncology
Volume4
Issue number9
Publication statusPublished - 2009

Cite this